Biotech Firm Calyxt Goes Public, Shares Climb 30 Percent
A U of M biotech startup filed last month to raise up to $50 million in an initial public offering.
Gene-editing company Calyxt Inc.’s shares gained almost 30 percent Wednesday on its first day trading as a public company. The New Brighton-based developer of agricultural gene-editing technology for food producers is the second Minnesota-based company to go public this year.
Read the full story in the Minneapolis/St. Paul Business Journal.